The most frequent reasons for using GLP-1 RAs among the participants were weight loss (80.4%) and control of blood sugar (53.3%), followed by a smaller group (29.4%) who said they used them to avoid obesity-related diseases. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.